ProPhase Labs, Inc. (PRPH) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

ProPhase Labs, Inc. (PRPH) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $420,486, listed on OTC, employing roughly 19 people, carrying a beta of 0.13 to the broader market. ProPhase Labs, Inc. Led by Ted William Karkus, public since 1994-04-04.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for PRPH as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →